Table 3.
Number of drug target genes identified for CHi-C genes enriched in significant pathways (Benjamini-Hochberg) for each disease, corresponding to the number of drugs and the potential for non-existing pathway gene targets for drug repositioning
| Disease | Genes identified by CHi-C (n) | Genes which are existing drug targets (n) | Drugs identified (n) | Drugs currently used (n) | Drugs for potential repositioning (n) | Potential pathway targets (n) | Potential pathway drugs (n) |
| RA | 50 | 13 | 38 | 8 | 30 | 283 | 398 |
| PsA | 9 | 2 | 2 | 0 | 2 | 47 | 87 |
| JIA | 10 | 2 | 4 | 0 | 4 | 205 | 325 |
| All | 59 | 14 | 39 | 8 | 31 | 307 | 412 |
CHi-C, Capture Hi-C; JIA, juvenile idiopathic arthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis.